» Articles » PMID: 36127318

Emerging Roles of Ferroptosis in Cardiovascular Diseases

Overview
Date 2022 Sep 20
PMID 36127318
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of cardiovascular diseases (CVDs) is complex and threatens human health. Cardiomyocyte death is an important participant in the pathophysiological basis of CVDs. Ferroptosis is a new type of iron-dependent programmed cell death caused by excessive accumulation of iron-dependent lipid peroxides and reactive oxygen species (ROS) and abnormal iron metabolism. Ferroptosis differs from other known cell death pathways, such as apoptosis, necrosis, necroptosis, autophagy and pyroptosis. Several compounds have been shown to induce or inhibit ferroptosis by regulating related key factors or signalling pathways. Recent studies have confirmed that ferroptosis is associated with the development of diverse CVDs and may be a potential therapeutic drug target for CVDs. In this review, we summarize the characteristics and related mechanisms of ferroptosis and focus on its role in CVDs, with the goal of inspiring novel treatment strategies.

Citing Articles

Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis.

Zhou Q, Wang Y, Si G, Chen X, Mu D, Zhang B Chem Biomed Imaging. 2025; 3(2):51-76.

PMID: 40018650 PMC: 11863161. DOI: 10.1021/cbmi.4c00064.


Insight into dipeptidase 1: structure, function, and mechanism in gastrointestinal cancer diseases.

Wang L, Tian G Transl Cancer Res. 2025; 13(12):7015-7025.

PMID: 39816548 PMC: 11730190. DOI: 10.21037/tcr-2024-2436.


Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches.

Zhou X, Wang H, Yan B, Nie X, Chen Q, Yang X Cardiovasc Drugs Ther. 2024; .

PMID: 39641901 DOI: 10.1007/s10557-024-07642-5.


Non-thermal atmospheric pressure plasma-irradiated cysteine protects cardiac ischemia/reperfusion injury by preserving supersulfides.

Nishimura A, Tanaka T, Shimoda K, Ida T, Sasaki S, Umezawa K Redox Biol. 2024; 79():103445.

PMID: 39637599 PMC: 11663985. DOI: 10.1016/j.redox.2024.103445.


Estrogen: the forgotten player in metaflammation.

Zhu B, Liao Q, Tian H, Yu D, Xie T, Sun X Front Pharmacol. 2024; 15:1478819.

PMID: 39575382 PMC: 11578702. DOI: 10.3389/fphar.2024.1478819.


References
1.
Wang J, Deng B, Liu Q, Huang Y, Chen W, Li J . Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis. 2020; 11(7):574. PMC: 7382480. DOI: 10.1038/s41419-020-02777-3. View

2.
Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G . Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021; 7(1):193. PMC: 8313570. DOI: 10.1038/s41420-021-00579-w. View

3.
Wu X, Li Y, Zhang S, Zhou X . Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021; 11(7):3052-3059. PMC: 7847684. DOI: 10.7150/thno.54113. View

4.
Son E, Lee D, Woo C, Kim Y . The optimal model of reperfusion injury using H9c2 transformed cardiac myoblasts. Korean J Physiol Pharmacol. 2020; 24(2):173-183. PMC: 7043999. DOI: 10.4196/kjpp.2020.24.2.173. View

5.
Bonora M, Giorgi C, Pinton P . Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2021; 23(4):266-285. DOI: 10.1038/s41580-021-00433-y. View